Advertisement
Screener

Bausch Health Companies Inc. (BHC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Bausch Health Companies Inc. Cash Flow Breakdown

Cash flow breakdown shows where Bausch Health Companies Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $1.40B came in.
  • Fiscal year ended 2025-12-31: from investing, $595.00M went out.
  • Fiscal year ended 2025-12-31: from financing, $742.00M went out.
  • Fiscal year ended 2025-12-31: change in cash, $124.00M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$1.40B-$595.00M-$11.19B$10.55B-$24.00M-$10.00M-$71.00M*$124.00M
2024-12-31$1.60B-$454.00M-$1.46B$661.00M-$26.00M-$11.00M-$32.00M*$239.00M
2023-12-31$1.03B-$2.15B-$1.71B$3.29B-$24.00M-$11.00M-$71.00M*$371.00M
2022-12-31-$728.00M-$303.00M-$7.85B$6.84B-$31.00M-$11.00M$578.00M*-$1.53B
2021-12-31$1.43B$409.00M-$3.44B$2.10B-$52.00M$10.00M-$131.00M*$303.00M
2020-12-31$1.11B-$261.00M-$5.64B$3.46B-$30.00M-$3.00M-$74.00M*-$1.43B
2019-12-31$1.50B-$419.00M-$4.41B$5.96B-$40.00M-$8.00M-$63.00M*$2.52B
2018-12-31$1.50B-$196.00M-$10.10B$8.94B-$10.00M-$26.00M-$160.00M*-$74.00M
2017-12-31$2.29B$2.89B$0.00-$14.20B$9.42B-$4.00M$0.00-$18.00M-$162.00M*$255.00M
2016-12-31$2.09B-$125.00M$0.00-$2.44B$1.22B-$11.00M$0.00-$9.00M-$727.00M*-$55.00M
2015-12-31$2.26B-$15.58B-$72.00M-$2.06B$17.82B-$88.00M$1.43B-$3.41B*$274.00M
2014-12-31$2.31B-$100.00M$0.00-$3.89B$1.63B-$44.00M$0.00-$158.00M*
2013-12-31$1.04B-$5.38B-$55.60M-$6.33B$8.39B-$65.50M$2.31B$24.20M-$242.00M*
2012-12-31$656.60M-$2.97B-$280.70M-$1.93B$6.01B-$31.10M$0.00$12.50M-$720.10M*
2011-12-31$640.47M-$2.81B-$639.24M-$2.00B$5.39B-$59.72M$0.00$26.53M-$763.57M*
2010-12-31$263.19M$228.94M-$60.13M-$356.29M-$537.50M$992.40M-$14.48M$58.42M$861.00K-$296.56M*$279.81M
2009-12-31$360.90M-$742.77M-$147.15M$350.00M$0.00*$866.00K-$399.00K-$26.27M*-$203.08M
2008-12-31$204.32M-$107.83M-$29.84M-$180.29M-$182.00K-$116.09M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$670.00M*-$93.00M*-$112.00M*$84.00M*-$8.00M*-$7.00M*-$6.00M*
2026-03-31$230.00M-$139.00M-$2.86B$2.80B-$34.00M-$2.00M-$9.00M*-$13.00M
2025-12-31$495.00M*-$282.00M*-$352.00M*$133.00M*$0.00*-$1.00M*-$15.00M*
2025-09-30$405.00M*-$83.00M*-$704.00M*-$1.00M*-$5.00M*-$1.00M*-$8.00M*
2025-06-30$289.00M*-$100.00M*-$9.97B*$10.37B*-$3.00M*-$8.00M*-$36.00M*
2025-03-31$211.00M-$130.00M-$168.00M$50.00M-$16.00M$0.00-$12.00M*-$44.00M
2024-12-31$601.00M*-$200.00M*-$411.00M*$506.00M*-$3.00M*-$2.00M*-$5.00M*
2024-09-30$405.00M*-$102.00M*-$164.00M*$0.00*-$5.00M*-$9.00M*-$11.00M*
2024-06-30$380.00M*-$79.00M*-$495.00M*$80.00M*-$4.00M*$0.00*-$5.00M*
2024-03-31$211.00M-$73.00M-$390.00M$75.00M-$14.00M$0.00-$11.00M*-$207.00M
2023-12-31$390.00M*-$148.00M*-$203.00M*$146.00M*-$1.00M*-$3.00M*-$18.00M*
2023-09-30$282.00M*-$1.89B*-$817.00M*$2.69B*-$8.00M*-$8.00M*-$41.00M*
2023-06-30$206.00M*-$30.00M*-$411.00M*$300.00M*-$3.00M*-$1.00M*-$5.00M*
2023-03-31$154.00M-$78.00M-$279.00M$155.00M-$12.00M$1.00M-$7.00M*-$60.00M
2022-12-31$475.00M*-$136.00M*-$622.00M*$355.00M*-$1.00M*-$1.00M*-$7.00M*
2022-09-30-$1.26B*-$53.00M*-$141.00M*$161.00M*-$1.00M*-$12.00M*-$43.00M*
2022-06-30$123.00M*-$58.00M*-$6.60B*$5.33B*-$4.00M*$1.00M*$637.00M*
2022-03-31-$63.00M-$56.00M-$485.00M$986.00M-$25.00M$1.00M-$9.00M*$341.00M
2021-12-31$24.00M*-$80.00M*-$240.00M*$524.00M*-$4.00M*$1.00M*-$6.00M*
2021-09-30$564.00M*$588.00M*-$1.10B*-$3.00M*-$3.00M*-$5.00M*-$46.00M*
2021-06-30$395.00M*-$43.00M*-$1.90B*$1.58B*-$4.00M*$3.00M*-$69.00M*
2021-03-31$443.00M-$56.00M-$200.00M-$3.00M-$41.00M$11.00M-$10.00M*$131.00M
2020-12-31$394.00M-$84.00M*-$2.48B*$1.98B*$0.00*$3.00M*-$5.00M*
2020-09-30$256.00M-$70.00M*-$100.00M*-$1.00M*-$1.00M*-$7.00M*-$8.00M*
2020-06-30$200.00M-$67.00M*-$1.60B*$1.48B*-$5.00M*$1.00M*-$26.00M*
2020-03-31$261.00M-$40.00M-$1.46B-$3.00M-$24.00M$0.00-$35.00M*-$1.32B
2019-12-31$234.00M-$85.00M*-$450.00M*$2.72B*$0.00*-$7.00M*-$10.00M*
2019-09-30$515.00M-$73.00M*-$453.00M*-$5.00M*-$1.00M*-$4.00M*-$11.00M*
2019-06-30$339.00M-$58.00M*-$1.88B*$1.73B*-$5.00M*$2.00M*-$32.00M*
2019-03-31$413.00M-$203.00M-$1.62B$1.51B-$34.00M$1.00M-$10.00M*$61.00M
2018-12-31$319.00M-$62.00M*-$1.90B*$1.47B*$0.00*$1.00M*-$21.00M*-$54.00M*
2018-09-30$522.00M$5.00M*-$364.00M*-$3.00M*-$2.00M*-$6.00M*-$11.00M*
2018-06-30$222.00M-$91.00M*-$6.11B*$5.99B*-$3.00M*$2.00M*-$64.00M*
2018-03-31$438.00M-$48.00M-$1.73B$1.48B-$5.00M-$1.00M-$32.00M*$112.00M
2017-12-31$578.00M$90.00M*-$4.95B*$3.19B*$0.00*$0.00*$0.00*-$81.00M*
2017-09-30$490.00M$869.00M*-$1.41B*-$1.00M*-$1.00M*$0.00*-$8.00M*-$10.00M*
2017-06-30$268.00M$780.00M*-$220.00M*-$2.00M*-$3.00M*$0.00*$0.00*-$24.00M*
2017-03-31$954.00M$1.15B-$7.62B$6.23B$0.00$0.00-$10.00M*-$47.00M*$668.00M
2016-12-31$512.00M$6.00M*$0.00*-$519.00M*$0.00*-$2.00M*$0.00*-$1.00M*-$53.00M*
2016-09-30$569.00M-$69.00M*$0.00*-$644.00M*$0.00*-$2.00M*$0.00*-$1.00M*-$50.00M*-$193.90M*
2016-06-30$449.00M$50.00M*-$847.00M*$0.00*$1.00M*$0.00*-$8.40M*-$96.60M*-$457.90M*
2016-03-31$556.00M-$112.00M-$426.00M$1.22B-$8.00M$0.00$0.00*-$526.00M*$713.00M
2015-12-31$598.00M-$1.54B*-$22.00M*-$667.80M*$891.20M*-$2.20M*-$700.00K*$35.10M*-$111.10M*
2015-09-30$733.00M-$156.20M$0.00-$29.00M$0.00-$24.30M$0.00-$13.80M*-$41.40M*$462.00M
2015-06-30$418.00M-$2.65B-$50.00M-$247.90M$4.92B-$45.60M$0.00$6.40M*-$3.26B*-$906.40M*
2015-03-31$509.00M-$11.24B-$1.11B$12.00B-$15.90M$1.43B$17.90M*-$20.10M*$1.54B
2014-12-31$815.70M-$205.80M*$0.00*-$1.70B*$666.60M*-$5.50M*$0.00*$0.00*-$55.70M*
2014-09-30$618.70M$756.30M$0.00-$1.63B$555.00M-$2.00M$0.00$15.50M*-$20.80M*$277.60M
2014-06-30$376.00M-$266.40M$0.00-$120.30M$49.30M-$8.80M$0.00-$7.70M*-$69.10M*
2014-03-31$484.30M-$384.10M$0.00-$433.90M$360.60M-$27.70M$0.00-$5.60M*-$16.10M*
2013-12-31$279.86M*-$144.59M*$0.00*-$940.40M*$880.30M*-$29.60M*$37.50M*-$24.40M*-$54.25M*
2013-09-30$201.70M-$4.47B$0.00-$4.78B$7.17B-$14.40M-$1.30M$30.10M*-$80.00M*
2013-06-30$305.10M-$531.70M-$20.60M-$174.70M$340.00M-$14.70M$2.27B$11.80M*-$56.90M*
2013-03-31$255.30M-$234.90M-$35.00M-$430.00M$0.00-$6.80M$2.60M$4.60M-$51.30M*
2012-12-31$67.92M*-$1.97B*$24.00K*-$1.47B*$4.60B*-$9.99M*$0.00*$6.66M*-$563.38M*
2012-09-30$166.83M-$297.40M$0.00-$31.06M$122.30M-$7.38M$0.00$2.37M-$94.16M*
2012-06-30$254.60M-$476.14M-$172.00M-$127.18M$640.77M-$9.91M$0.00$2.88M-$42.06M*
2012-03-31$167.23M-$218.38M-$108.72M-$302.81M$645.64M-$3.82M$5.11M$593.00K-$25.55M*
2011-12-31$189.78M*-$1.51B*-$65.12M*-$1.02B*$2.46B*-$2.56M*$7.53M*-$7.13M*-$136.74M*
2011-09-30$173.71M-$442.62M-$74.56M-$11.09M$690.00M-$2.48M$4.85M$2.04M-$309.74M*
2011-06-30$226.66M-$62.50M-$224.81M$0.00$0.00*$100.00M$100.00M-$15.20M$6.13M$7.57M-$303.85M*-$162.81M
2011-03-31$86.33M-$825.33M-$274.75M-$975.00M$2.14B-$39.48M$23.23M$24.05M-$154.97M*$7.48M
2010-12-31-$1.40M*-$33.20M*-$312.73M*-$525.00M*$51.15M*$622.08M*-$198.38M*
2010-09-30$110.92M$315.37M-$15.06M$0.00*$4.47M$416.09M
2010-06-30$108.91M-$9.35M-$14.26M-$12.50M$1.25M$73.67M
2010-03-31$44.75M-$43.88M-$14.25M$1.54M-$11.57M
2009-12-31$127.65M*$5.54M*-$14.24M*-$55.00M*$822.00K*-$6.00K*$65.06M*
2009-09-30$89.20M-$4.51M-$14.24M-$75.00M*$26.00K$0.00*-$3.51M
2009-06-30$97.08M-$736.75M-$59.33M$130.00M$18.00K-$393.00K$323.73M*-$244.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42